Ask AI
ProCE Banner Series

CAR-T vs HCT: Optimizing Bridging, Sequencing, and Relapse Decisions in B-Cell Lymphomas

This 1.0-hour interactive satellite symposium held in conjunction with the Tandem Meetings in Orlando, Florida, will feature presentations and panel discussions with perspectives and recommendations from multiple experts on the latest clinical developments and guidance about current and emerging evidence for the use of CAR T-cell therapy vs hematopoietic cell transplantation for patients with B-cell lymphomas.

Please note: Only registered attendees of the Tandem Meetings can attend this symposium. Tandem Meetings registration is available here: https://www.tandemmeetings.com/Registration/Registration-Information

Who Should Attend

This educational activity is intended for transplant physicians, cellular therapy specialists, hematologists/oncologists, APPs, nurses, pharmacists, CAR T-cell coordinators, and other multidisciplinary HCPs who evaluate, refer, treat, or monitor patients with B-cell lymphomas before or after CAR T-cell therapy.

All Events

CAR-T vs HCT: Optimizing Bridging, Sequencing, and Relapse Decisions in B-Cell Lymphomas

Upcoming Events

February

19

2027

6:30 AM - 8:00 AM Eastern Time (ET)

In-person

Orlando World Center Marriott, 8701 World Center Dr., Orlando, Florida 32821

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence to apply a practical, guideline-aligned framework for referral, sequencing, toxicity management, and post–CAR T-cell relapse decision-making in patients with B-cell lymphomas who may be candidates for CAR T-cell therapy. 

Target Audience
This educational activity is intended for transplant physicians, cellular therapy specialists, hematologists/oncologists, APPs, nurses, pharmacists, CAR T-cell coordinators, and other multidisciplinary HCPs who evaluate, refer, treat, or monitor patients with B-cell lymphomas before or after CAR T-cell therapy.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Evaluate current and emerging evidence for CD19-directed CAR T-cell therapy across LBCL/DLBCL, transformed indolent lymphoma, FL, MCL, and MZL, including implications for autologous HCT, selected allogeneic HCT, and post–CAR T-cell treatment sequencing
  • Apply evidence-based criteria to optimize CAR T-cell referral, leukapheresis timing, holding/bridging therapy selection, and sequencing with autologous HCT, bispecific antibodies, ADC-based regimens, targeted agents, and clinical trials
  • Recognize and manage CAR T-cell–associated toxicities to support safe recovery, surveillance, and subsequent treatment planning

Accreditation

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education to physicians.

AMA Credit Designation

The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by the Medical College of Wisconsin.

Medical College of Wisconsin

Supporters

This activity is supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

For customer support please click here.

Mailing Address:

 

Decera Clinical
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191